Focused on “Precision Through Omics”, RCIRC recently concluded a two-day academic programme, uniting leading oncologists, pathologists, and molecular diagnostics experts to discuss integrating genomic and molecular data into cancer care. Sessions highlighted cutting-edge technologies like next-gen sequencing and liquid biopsy, emphasizing how molecular insights can drive personalized treatment.